CD274 and non-small cell lung carcinoma: In non-small cell lung cancer, the Akt−Stat3 pathway has been reported to be a promising target for immunotherapy targeting PD-L1 [29], and Choi et al. reported the association between PD-L1 and pStat3 in OSCC cells [30].